Self nanoemulsifying drug delivery system (SNEDDS) of Rosuvastatin calcium: Design, formulation, bioavailability and pharmacokinetic evaluation

Colloids and Surfaces B: Biointerfaces

Volumn 112, Issue , 2013, Pages 337-343

  Balakumar, Krishnamoorthy ^a   Raghavan, Chellan Vijaya ^a   selvan, Natarajan Tamil ^a   prasad, Ranganathan Hari ^a   Abdu, Siyad ^a  

^a PSG COLLEGE OF PHARMACY   (India)

Author keywords

Bioavailability; Pharmacokinetic study; Poorly water soluble drug; Rosuvastatin calcium; Self nanoemulsifying drug delivery system; SNEDDS

Indexed keywords

BIOAVAILABILITY; DRUG DELIVERY SYSTEM; PHARMACOKINETIC STUDIES; POORLY WATER-SOLUBLE DRUGS; ROSUVASTATIN CALCIUMS; SNEDDS;

CALCIUM; DRUG DELIVERY; EMULSIFICATION; ESSENTIAL OILS; PARTICLE SIZE ANALYSIS; PHARMACOKINETICS; SOLUBILITY; SURFACE ACTIVE AGENTS; ZETA POTENTIAL;

BIOCHEMISTRY;

CINNAMON OIL; COSURFACTANT; ESSENTIAL OIL; LABRASOL; LAVENDER OIL; OCTANOIN; PEPPERMINT OIL; POLIDOCANOL; ROSUVASTATIN; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DILUTION; DROPLET SIZE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG HALF LIFE; DRUG MARKETING; DRUG RELEASE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PH; PHYSICAL PARAMETERS; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RAT; SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM; SUSPENSION; TIME TO MAXIMUM PLASMA CONCENTRATION; ZETA POTENTIAL;

BIOAVAILABILITY; PHARMACOKINETIC STUDY; POORLY WATER SOLUBLE DRUG; ROSUVASTATIN CALCIUM; SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM; SNEDDS;

ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; FLUOROBENZENES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEMBRANE POTENTIALS; NANOSTRUCTURES; OILS; PARTICLE SIZE; PYRIMIDINES; RATS; RATS, WISTAR; SOLUBILITY; SULFONAMIDES; SURFACE-ACTIVE AGENTS;

EID: 84883728108     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.08.025     Document Type: Article

References (39)

1. Park M.J., Ren S., Lee B.J. In vitro and in vivo comparative study of itraconazole bioavailability when formulated in highly soluble self-emulsifying system and in solid dispersion. Biopharm. Drug Dispos. 2007, 28:199-207.
2. Jeevana J.B., Sreelakshmi K. Design and evaluation of self-nanoemulsifying drug delivery system of flutamide. J. Young Pharm. 2011, 3:4-8.
3. Pouton C.W. Lipid formulations for oral administration of drugs: nonemulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci. 2000, 11:S93-S98.
4. Fatouros D.G., Karpf D.M., Nielsen F.S., Mullertz A. Clinical studies with oral lipid based formulations of poorly soluble compounds. Ther. Clin. Risk Manag. 2007, 3:591-604.
5. Wang L., Dong J., Chen J., Eastoe J., Li X. Design and optimization of a new self-nanoemulsifying drug delivery system. J. Colloid Interface Sci. 2009, 330:443-448.
6. Chakraborty S., Shukla D., Mishra B., Singh S. Lipid - an emerging platform for oral delivery of drugs with poor bioavailability. Eur. J. Pharm. Biopharm. 2009, 73:1-70.
7. Fatouros D.G., Bergenstahl B., Müllertz A. Morphological observations on a lipid-based drug delivery system during in vitro digestion. Eur. J. Pharm. Sci. 2007, 31:85-94.
8. Lennernäs H., Fager G. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors: similarities and differences. Clin. Pharmacokinet. 1997, 32:403.
9. Schachter M. Chemical, pharmacokinetic and pharmacodynamics properties of statins: an update. Fund. Clin. Pharmacol. 2004, 19:117-125.
10. Fritz Blatter, Crystalline forms of Rosuvastatin calcium salt, US Patent No. 20080194604A1 (2008).
11. Shlomit Wizel, Crystalline Rosuvastatin calcium, US Patent No. 20080176878A1 (2008).
12. Valerie Niddam Hildesheim, Crystalline Rosuvastatin calcium intermediate, US Patent No. 20070123550A1 (2007).
13. Nazzal S., Smalyukh I.I., Lavrentovich O.D., Khan M.A. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int. J. Pharm. 2002, 235(1-2):247-265.
14. Sevda R.R., Ravetkar A.S., Shirote P.J. UV spectrophotometric estimation of Rosuvastatin calcium and fenofibrate in bulk drug and dosage form using simultaneous equation method. Int. J. Chem. Tech. Res. 2011, 3:629-635.
15. Gupta A.K., Mishra D.K., Mahajan S.C. Preparation and in-vitro evaluation of self emulsifying drug delivery system of antihypertensive drug valsartan. Int. J. Pharm. Life Sci. 2011, 2:633-639.
16. Mahmoud E.A., Bendas E.R., Mohamed M.I. Preparation and evaluation of self-nanoemulsifying tablets of carvedilol. AAPS Pharm. Sci. Tech. 2009, 10:183-192.
17. Zhang P., Liu Y., Feng N., Xu J. Preparation and evaluation of self microemulsifiying drug delivery system of oridonin. Int. J. Pharm. 2008, 355:269-276.
18. Kawakami K., Yoshikawa T., Moroto Y., Kanaoka E., Takahashi K., Nishihara Y., Masuda K. Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. Prescription design. J. Control. Rel. 2000, 81:65-74.
19. Kim J.Y., Ku Y.S. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats. Int. J. Pharm. 2000, 194:81-89.
20. Nagarsenker M.S., Date A.A. Design and evaluation of self-nanoemulsifying drug delivery (SNEDDS) for cefpodoxime proxetil. Int. J. Pharm. 2007, 329:166-172.
21. Elnaggar Y.S.R., El-Massik M.A., Abdallah O.Y. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int. J. Pharm. 2009, 380:133-141.
22. Kumar T.R., Shitut N.R., Kumar P.K., Vinu M.C.A., Kumar V.V.P., Mullangi R., Srinivas N.R. Determination of rosuvastatin in rat plasma by HPLC: validation and its application to pharmacokinetic studies. Biomed. Chromatogr. 2006, 20:881-887.
23. Kaila H.O., Ambasana M.A., Thakkar R.S., Saravaia H.T., Shah A.K. A new improved RP-HPLC method for assay of Rosuvastatin calcium in tablets. Indian J. Pharm. Sci. 2010, 72:592-598.
24. Yamaoka K., Nakagawa T., Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 1978, 6:165-175.
25. Kommura T.R., Gurley B., Khan M.A., Reddy I.K. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm. 2001, 212:233-246.
26. J.N. Chang, O. Olejnik, Bruce A. Firestone, Cyclosporin compositions, U.S. Patent 7276476 (2005).
27. Sharma S., Bajaj H., Bhardwaj P., Sharma A.D., Singh R. Development and characterization of self emulsifying drug delivery system of a poorly water soluble drug using natural oil. Acta Pol. Pharm. 2012, 69:713-717.
28. Wacher V.J., Wong S., Wong H.T. Peppermint oil enhances cyclosporine oral bioavailability in rats: comparison with D-alpha-tocopheryl poly(ethylene glycol 1000) succinate (TPGS) and ketoconazole. J. Pharm. Sci. 2002, 91:77-90.
29. Karpf D.M., Holm R., Kristensen H.G., Müllertz A. Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats. Pharm. Res. 2004, 21:1413-1418.
30. Balakrishnan P., Lee B.J., Oh D.H., Kim J.O., Hong M.J., Jee J.P., Kim J.A., Yoo B.K., Woo J.S., Yong C.S., Choi H.G. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery systems (SEDDS). Eur. J. Pharm. Biopharm. 2009, 72:539-545.
31. Basalious E.B., Shawky N., Badr-Eldin S.M. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimization. Int. J. Pharm. 2010, 391:203-211.
32. Constantinides P.P. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 1995, 12:1561-1572.
33. Gupta S., Chavhan S., Sawant K.K. Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf. A: Physicochem. Eng. Aspects. 2011, 392:145-155.
34. Xi J., Chang Q., Chan C.K., Meng Z.Y., Wang G.N., Sun J.B., Wang Y.T., Tong H.H.Y., Zheng Y. Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS Pharm. Sci. Tech. 2009, 10:172-182.
35. Patel J., Patel A., Raval M., Sheth N. Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan. J. Adv. Pharm. Technol. Res. 2011, 2:9-16.
36. Muller R.H., Jacobs C., Kayser O. Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 2001, 47:3-19.
37. Shukla J.B., Patel S.J. Formulation and evaluation of self micro emulsifying system of Candesartan cilexetil. Int. J. Pharm. Pharm. Sci. 2010, 2:143-146.
38. Wu W., Wang Y., Que L. Enhanced bioavailability of silymarin by elfmicroemulsifying drug delivery system. Eur. J. Pharm. Biopharm. 2006, 63:288-294.
39. Zhang H., Zhang F.M., Yan S.J. Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles. Int. J. Nanomed. 2012, 7:2901-2910.